Stockreport

KalVista Pharmaceuticals Provides Operational Update and Reports Third Quarter Financial Results

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF US launch of EKTERLY® gaining strong momentum with $13.7 million in net product revenue for the third quarter937 patient start forms received through October, reflecting [Read more]